Sunaga N[au] - Search Results

Year	Number of Results
1993	1
1994	1
1996	1
1999	1
2000	3
2001	4
2002	4
2003	2
2004	4
2005	3
2006	7
2007	20
2008	14
2009	21
2010	9
2011	4
2012	6
2013	7
2014	9
2015	8
2016	3
2017	11
2018	9
2019	8
2020	8
2021	3
2022	7
2023	0

1

Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, Yoshimi S, Yatomi M, Shin Y, Wakamatsu I, Umetsu K, Kouno S, Nakagawa J, Sunaga N, Maeno T, Hisada T. Takehara K, et al. Among authors: sunaga n. Cells. 2022 Jan 2;11(1):143. doi: 10.3390/cells11010143. Cells. 2022. PMID: 35011705 Free PMC article.

2

DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers.

Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF. Suzuki M, et al. Among authors: sunaga n. Br J Cancer. 2013 Dec 10;109(12):3132. doi: 10.1038/bjc.2013.776. Br J Cancer. 2013. PMID: 24327071 Free PMC article. No abstract available.

3

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Sunaga N, Miura Y, Kasahara N, Sakurai R. Sunaga N, et al. Cancers (Basel). 2021 Nov 26;13(23):5956. doi: 10.3390/cancers13235956. Cancers (Basel). 2021. PMID: 34885068 Free PMC article. Review.

4

A pregnant woman with severe dyspnoea.

Kanbe M, Yatomi M, Wakamatsu I, Uno S, Hanazato C, Aoki-Saito H, Masuda T, Yamaguchi K, Kasahara N, Miura Y, Tsurumaki H, Hara K, Koga Y, Sunaga N, Higeta D, Kameda T, Hisada T, Maeno T. Kanbe M, et al. Among authors: sunaga n. Breathe (Sheff). 2022 Jun;18(2):220012. doi: 10.1183/20734735.0012-2022. Epub 2022 Jul 12. Breathe (Sheff). 2022. PMID: 36337132 Free PMC article.

5

Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer.

Miura Y, Sunaga N. Miura Y, et al. Among authors: sunaga n. Cancers (Basel). 2018 Jul 27;10(8):245. doi: 10.3390/cancers10080245. Cancers (Basel). 2018. PMID: 30060457 Free PMC article. Review.

6

Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer.

Miura Y, Kasahara N, Sunaga N. Miura Y, et al. Among authors: sunaga n. Transl Cancer Res. 2019 Dec;8(Suppl 6):S628-S632. doi: 10.21037/tcr.2019.10.08. Transl Cancer Res. 2019. PMID: 35117146 Free PMC article. No abstract available.

7

Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease.

Ito M, Koga Y, Hachisu Y, Murata K, Sunaga N, Maeno T, Hisada T. Ito M, et al. Among authors: sunaga n. Respir Investig. 2022 Sep;60(5):613-624. doi: 10.1016/j.resinv.2022.05.006. Epub 2022 Jun 30. Respir Investig. 2022. PMID: 35781424 Review.

8

Epiregulin as a therapeutic target in non-small-cell lung cancer.

Sunaga N, Kaira K. Sunaga N, et al. Lung Cancer (Auckl). 2015 Oct 12;6:91-98. doi: 10.2147/LCTT.S60427. eCollection 2015. Lung Cancer (Auckl). 2015. PMID: 28210154 Free PMC article. Review.

9

FAM83G Is a Novel Inducer of Apoptosis.

Okada J, Sunaga N, Yamada E, Saito T, Ozawa A, Nakajima Y, Okada K, Pessin JE, Okada S, Yamada M. Okada J, et al. Among authors: sunaga n. Molecules. 2020 Jun 18;25(12):2810. doi: 10.3390/molecules25122810. Molecules. 2020. PMID: 32570757 Free PMC article.

10

The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.

Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N. Kaira K, et al. Among authors: sunaga n. Cancer Imaging. 2011 Nov 30;11(1):195-201. doi: 10.1102/1470-7330.2011.0028. Cancer Imaging. 2011. PMID: 22138614 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results